About Us
Improving Patient Outcomes One IV at a Time
ivWatch was established with the mission to eliminate the harm done by IV infiltrations and extravasations to help improve patient outcomes. At ivWatch, we believe that by working together, we can enhance patient safety, advance patient care, and set a new standard in healthcare.
Our Leadership Team

Gary Warren

Kathy Cox

Jaclyn Lautz, PhD

Erin Wendell

Holly Novak

Helen Stephens
“I want to type in ‘IV Infiltration’ into a search engine in 10 years and the horrible images are all gone.”
PRESIDENT & CEO, GARY WARREN
Our Story
Founded in 2010, ivWatch continues our mission with a singular focus to prevent patient harm by monitoring and detecting IV infiltrations. Our company and our technology have continuously evolved, developing and bringing to market the world’s first sensors and monitor that are uniquely created to detect peripheral IV infiltrations at their earliest stages. Our innovative design offers clinicians the ability to intervene well before harm can be seen by the human eye to enhance patient safety and reduce liability.
Today, ivWatch teams, including research and development, manufacturing, clinical, sales, and marketing, are supported by key partnerships and a network of international distributors. These relationships allow us to bring our one-of-a-kind solutions to the global healthcare market.
created to detect peripheral IV
Today, ivWatch teams, including research and development, manufacturing, clinical, sales, and marketing, are supported by key partnerships and a network of international distributors. These relationships allow us to bring our one-of-a-kind solutions to the global healthcare market.



NIH Grant Phase 1 | Animal Testing
Feasibility of optical measurement to detect infiltrations.
2001-2009

NIH Grant Phase 2 | Human Volunteer Testing
Prototype results indicate high sensor sensitivity.

NIH Grant Continuation | Hospital Patient Testing
Technology tested in a clinical setting.
2010
2011


ivWatch, LLC Established
From small research company to ivWatch, LLC.


Pediatric Pilot Study
127 pediatric patient pilot study using a prototype at Cincinnati Children’s Hospital.
2012
2013-2014

Validation Studies
– Internal Clinical Studies resulted in high accuracy sensor performance.
– Developed the algorithm that compensates for patient motion.
Study included in FDA submission for patients over 18.
MODEL 400 PATIENT MONITORING SYSTEM DESIGN & DEVELOPMENT

FDA Clearance | Model 400 Patient Monitoring System
Initial submission for use in adult population cleared.
Developed In-House Manufacturing Capability
2015
2016

Cincinnati Children’s Hospital Study
Pediatric study conducted in support of clearance for all age groups.

FDA Clearance | Use in Pediatric Population

Model 400 Patient Monitoring System Launch
Product availability in the US.
2017
2018

Integration with Philips Intellivue
New software release.
SMARTTOUCH SENSOR DESIGN & DEVELOPMENT

SmartTouch Validation
Clinical Studies
2019
2020


SmartTouch FDA Clearance & Product Launch
Our Values
What we stand for and believe in as a company
The values listed below continuously guide us in delivering exceptional solutions to you and your patients. They are the cornerstone of our brand and the elements that make ivWatch the leader in early IV infiltration detection.
Authentic
We believe in the importance of being a genuine part of the patient’s journey. By empathizing with them from admission to discharge, we strive to meet and exceed their needs.
Trustworthy
We are committed to building genuine, long-term relationships with our customers. We will be there when you need us and remain always accountable and committed to you and your patients.
Patient-centric
Everything we do centers around the patient. We live and breathe every aspect of a patient’s experience. We are relentless in prioritizing their needs through innovative design and outstanding service.
Better Together
We believe in partnering with hospitals, clinicians, and patients to improve our technology and advance care. We believe that hospitals and clinicians are heroes; together, we can make patients better.
Our Partnerships
ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, entered into a long-term development and commercialization agreement with ICU Medical, a worldwide leader in the development, manufacture, and sale of innovative medical devices used in infusion therapy and critical care applications. The collaboration will offer a way forward for Electronic Health Records (EHR) interoperability by connecting the two companies’ systems to exchange and use high-quality data.
READ PRESS RELEASE

ivWatch has announced compatibility with Philips IntelliVue Patient Monitors with the inclusion of point-of-connectivity. As the only provider of continuous non-invasive monitoring devices for the early detection of peripheral intravenous (IV) infiltrations and extravasations, ivWatch now supports Philips IntelliVue Patient Monitors for in-room and remote notifications and electronic medical record (EMR) data capture.
READ PRESS RELEASE

ivWatch is the market leader for continuous IV infiltration and extravasation detection technology and Terumo Corporation is one of the world’s leading medical device manufacturers and distributors.
READ PRESS RELEASE

ivWatch, LLC has been awarded a group purchasing agreement for Patient Safety Solutions with Premier, Inc. to provide more than 4,000 U.S. Premier member hospitals and approximately 200,000 other providers and organizations with greater access to the only continuous peripheral IV site monitoring technology available in the market. The three-year agreement underscores the importance of detecting IV infiltration and extravasation events early to advance patient safety and create a new standard of care. Premier members can contact their Premier account manager or contact Sales@ivWatch.com to take advantage of special pricing and terms pre-negotiated for the ivWatch Model 400 system.
READ PRESS RELEASE

ivWatch has been designated a Vizient awarded supplier by Vizient, Inc., the largest member-driven health care performance improvement company in the country. The ivWatch Model 400 has earned an Innovative Technology designation based on recommendations for the device by providers with expertise in this category. Innovative Technology contracts are reserved for technologies that demonstrate an ability to enhance clinical care or patient safety, and those that improve an organization’s care delivery and business model. Vizient-served members can contact their Vizient account manager or access additional information on the ivWatch Model 400 through the Vizient member portal.
READ PRESS RELEASE

ICU Medical
ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, entered into a long-term development and commercialization agreement with ICU Medical, a worldwide leader in the development, manufacture, and sale of innovative medical devices used in infusion therapy and critical care applications. The collaboration will offer a way forward for Electronic Health Records (EHR) interoperability by connecting the two companies’ systems to exchange and use high-quality data.
READ PRESS RELEASE
Philips
ivWatch has announced compatibility with Philips IntelliVue Patient Monitors with the inclusion of point-of-connectivity. As the only provider of continuous non-invasive monitoring devices for the early detection of peripheral intravenous (IV) infiltrations and extravasations, ivWatch now supports Philips IntelliVue Patient Monitors for in-room and remote notifications and electronic medical record (EMR) data capture.
READ PRESS RELEASE
Terumo
ivWatch and Terumo entered into a licensing and distribution agreement to help improve patient safety. As part of the agreement, Terumo Corporation is named as the exclusive distributor for the ivWatch Model 400 in Japan and has licensed the ivWatch OEM board to provide continuous IV infiltration detection technology in Terumo products globally.
ivWatch is the market leader for continuous IV infiltration and extravasation detection technology and Terumo Corporation is one of the world’s leading medical device manufacturers and distributors.
READ PRESS RELEASE
Premier
ivWatch, LLC has been awarded a group purchasing agreement for Patient Safety Solutions with Premier, Inc. to provide more than 4,000 U.S. Premier member hospitals and approximately 200,000 other providers and organizations with greater access to the only continuous peripheral IV site monitoring technology available in the market. The three-year agreement underscores the importance of detecting IV infiltration and extravasation events early to advance patient safety and create a new standard of care. Premier members can contact their Premier account manager or contact Sales@ivWatch.com to take advantage of special pricing and terms pre-negotiated for the ivWatch Model 400 system.
READ PRESS RELEASE
Vizient
ivWatch has been designated a Vizient awarded supplier by Vizient, Inc., the largest member-driven health care performance improvement company in the country. The ivWatch Model 400 has earned an Innovative Technology designation based on recommendations for the device by providers with expertise in this category. Innovative Technology contracts are reserved for technologies that demonstrate an ability to enhance clinical care or patient safety, and those that improve an organization’s care delivery and business model. Vizient-served members can contact their Vizient account manager or access additional information on the ivWatch Model 400 through the Vizient member portal.
READ PRESS RELEASE
Our Distributors
As the exclusive distributor for ivWatch products in the Netherlands, QRS offers local sales, service, support and clinical services for ivWatch in addition to their line of innovative medical devices and disposables.
Evoluzione is the exclusive distributor of ivWatch products in Italy. Specializing in innovative vascular access and patient safety medical devices, Evoluzione provides local sales, service, support and clinical services for the ivWatch product line.
Emitac Healthcare Solutions has partnered with ivWatch to distribute our ground-breaking technology in the United Arab Emirates. As an exclusive ivWatch distributor, Emitac provides the innovative ivWatch Patient Monitoring System, as well as support, service, and clinical services along with their array of superior quality, cost-effective services and solutions to the healthcare community in the UAE.
Tamer Group is a leading distributor of medical equipment and supplies in the Kingdom of Saudi Arabia. Tamer Group leverages their expertise and deep connections in market to distribute ivWatch products and provide in-service training and support.
READ PRESS RELEASE
READ PRESS RELEASE
READ PRESS RELEASE
ivWatch and Terumo entered into a licensing and distribution agreement to help improve patient safety. As part of the agreement, Terumo Corporation is named as the exclusive distributor for the ivWatch Model 400 in Japan and has licensed the ivWatch OEM board to provide continuous IV infiltration detection technology in Terumo products globally. Terumo Corporation is one of the world’s leading medical device manufacturers and distributors.
READ PRESS RELEASE
QRS
As the exclusive distributor for ivWatch products in the Netherlands, QRS offers local sales, service, support and clinical services for ivWatch in addition to their line of innovative medical devices and disposables.
Evoluzione
Evoluzione is the exclusive distributor of ivWatch products in Italy. Specializing in innovative vascular access and patient safety medical devices, Evoluzione provides local sales, service, support and clinical services for the ivWatch product line.
Emitac
Emitac Healthcare Solutions has partnered with ivWatch to distribute our ground-breaking technology in the United Arab Emirates. As an exclusive ivWatch distributor, Emitac provides the innovative ivWatch Patient Monitoring System, as well as support, service, and clinical services along with their array of superior quality, cost-effective services and solutions to the healthcare community in the UAE.
Tamer Group
Tamer Group is a leading distributor of medical equipment and supplies in the Kingdom of Saudi Arabia. Tamer Group leverages their expertise and deep connections in market to distribute ivWatch products and provide in-service training and support.
READ PRESS RELEASE
New Medical
ivWatch and New Medical enter into international distribution partnership to manage the distribution of the ivWatch Model 400 in Australia and New Zealand. New Medical is a supplier of medical consumables, devices and patient monitoring accessories.
READ PRESS RELEASE
Roxon
ivWatch and Roxon medi-tech enter into an international distribution partnership to manage the distribution of the ivWatch Model 400. Roxon medi-tech focuses on supplying quality specialized medical equipment to medical facilities across Canada.
READ PRESS RELEASE
Sedeer
ivWatch and Sedeer Medical Services enter into international distribution partnership to manage the distribution of the ivWatch Model 400 in Qatar. Sedeer Medical aims to raise the bar in the field of health care by utilizing state-of-the-art technology, constantly in touch with new breakthroughs and developments.
READ PRESS RELEASE
Terumo
ivWatch and Terumo entered into a licensing and distribution agreement to help improve patient safety. As part of the agreement, Terumo Corporation is named as the exclusive distributor for the ivWatch Model 400 in Japan and has licensed the ivWatch OEM board to provide continuous IV infiltration detection technology in Terumo products globally. Terumo Corporation is one of the world’s leading medical device manufacturers and distributors.
READ PRESS RELEASE